Table 4 Univariate and multivariate analysis of the study variables in women

Age grouped

411,869

41–50

120,969 (29.4%)

1

–

1

–

51–60

97,887 (23.8%)

2.8

(2.5–3.1)

2.5

(2.2–2.8)

61–70

81,798 (19.9%)

4.2

(3.8–4.7)

4.7

(4.1–5.3)

71–80

61,424 (14.9%)

7.1

(6.3–7.9)

8.9

(7.8–10.1)

80 or more

49,791 (12.1%)

11.0

(9.8–12.2)

14.5

(12.7–16.6)

Smoking

411,869

89,687 (21.8%)

2.4

(2.3–2.5)

4.7

(4.4–5)

Lung Cancer

411,869

502 (0.1%)

5.9

(4.2–8.2)

3.6

(2.5–5.2)

Bronchiectasis

411,869

4994 (1.2%)

32.6

(30.4–35)

27.1

(25–29.3)

Lung Cancer

411,869

502 (0.1%)

5.9

(4.2–8.2)

3.6

(2.5–5.2)

Cor Pulmonale

411,869

505 (0.1%)

13.2

(10.3–16.9)

3.1

(2.3–4.1)

Heart Failure

411,869

8770 (2.1%)

8.2

(7.6–8.9)

3.0

(2.7–3.3)

OSAS

411,869

2884 (0.7%)

4.4

(3.7–5.2)

2.2

(1.8–2.6)

Alcohol Consumption Risk Rate

411,869

No intake

172,572 (41.9%)

1

1

Low

33,322 (8.1%)

0.9

(0.8–1)

0.9

(0.9–1)

Moderate or High

1277 (0.3%)

1.9

(1.4–2.5)

1.6

(1.2–2.3)

NA

204,698 (49.7%)

0.4

(0.4–0.4)

0.8

(0.7–0.8)

Ischaemic Cardiomyopathy (no AMI)

411,869

6400 (1.6%)

3.7

(3.3–4.1)

1.3

(1.1–1.5)

Osteopathy

411,869

46,798 (11.4%)

2.2

(2.1–2.4)

1.3

(1.2–1.4)

Depression

411,869

76,067 (18.5%)

1.6

(1.5–1.7)

1.3

(1.2–1.3)

Hypertension

411,869

145,272 (35.3%)

3.0

(2.8–3.1)

1.2

(1.1–1.3)

DM2

411,869

47,166 (11.5%)

2.3

(2.1–2.4)

1.1

(1–1.2)

Anaemia

411,869

46,826 (11.4%)

1.5

(1.4–1.6)

1.1

(1–1.2)

FA

411,869

13,301 (3.2%)

4.0

(3.7–4.3)

1.1

(1–1.3)

Chronic kidney failure

411,869

15,814 (3.8%)

3.0

(2.8–3.3)

1.1

(1–1.2)

Dyslipidaemia

411,869

139,208 (33.8%)

1.8

(1.7–1.9)

1.0

(0.9–1)

Grouped BMI

411,869

Normal

37,589 (9.1%)

1

–

1.0

–

Overweight

59,722 (14.5%)

0.9

(0.8–1)

0.8

(0.7–0.9)

Obesity

59,011 (14.3%)

1.2

(1.1–1.3)

1.0

(0.9–1.1)

NA

255,547 (62%)

0.4

(0.4–0.5)

0.9

(0.8–1)

ROC Curve

0.863 (0.86–0.87)